ArticleBreast cancer research and treatment2021
Risk evaluation of early-stage hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients: a population-based study from Taiwan.
Lei Lei et al.PubMed ↗Publisher ↗
No numbers read from the abstract.